Oseltamivir Ring Prophylaxis for Containment of 2009 H1N1 Influenza Outbreaks

dc.contributor.authorLee, Vernon
dc.contributor.authorYap, Jonathan
dc.contributor.authorCook, Alex R
dc.contributor.authorChen, Mark
dc.contributor.authorTay, Joshua K
dc.contributor.authorTan, Boon Huan
dc.contributor.authorLoh, Jin Phang
dc.contributor.authorChew, Seok Wei
dc.contributor.authorKoh, Wee Hong
dc.contributor.authorLin, Raymond T P
dc.contributor.authorCui, Lin
dc.contributor.authorLee, Charlie W.H
dc.contributor.authorSung, Wing-Kin
dc.contributor.authorWong, Christopher W.
dc.contributor.authorHibberd, Martin L.
dc.contributor.authorKang, Wee Lee
dc.contributor.authorSeet, Benjamin
dc.contributor.authorTambyah, Paul A.
dc.date.accessioned2015-12-08T22:37:39Z
dc.date.issued2010
dc.date.updated2016-02-24T11:16:06Z
dc.description.abstractBackground: From June 22 through June 25, 2009, four outbreaks of infection with the pandemic influenza A (H1N1) virus occurred in Singapore military camps. We report the efficacy of ring chemoprophylaxis (geographically targeted containment by means of prophylaxis) with oseltamivir to control outbreaks of 2009 H1N1 influenza in semiclosed environments. Methods: All personnel with suspected infection were tested and clinically isolated if infection was confirmed. In addition, we administered postexposure ring chemoprophylaxis with oseltamivir and segregated the affected military units to contain the spread of the virus. All personnel were screened three times weekly both for virologic infection, by means of nasopharyngeal swabs and reverse-transcriptase- polymerase-chain-reaction assay with sequencing, and for clinical symptoms, by means of questionnaires. Results: A total of 1175 personnel were at risk across the four sites, with 1100 receiving oseltamivir prophylaxis. A total of 75 personnel (6.4%) were infected before the intervention, and 7 (0.6%) after the intervention. There was a significant reduction in the overall reproductive number (the number of new cases attributable to the index case), from 1.91 (95% credible interval, 1.50 to 2.36) before the intervention to 0.11 (95% credible interval, 0.05 to 0.20) after the intervention. Three of the four outbreaks showed a significant reduction in the rate of infection after the intervention. Molecular analysis revealed that all four outbreaks were derived from the New York lineage of the 2009 H1N1 virus and that cases within each outbreak were due to transmission rather than unrelated episodes of infection. Of the 816 personnel treated with oseltamivir who were surveyed, 63 (7.7%) reported mild, nonrespiratory side effects of the drug, with no severe adverse events. Conclusions: Oseltamivir ring chemoprophylaxis, together with prompt identification and isolation of infected personnel, was effective in reducing the impact of outbreaks of 2009 H1N1 influenza in semiclosed settings.
dc.identifier.issn0028-4793
dc.identifier.urihttp://hdl.handle.net/1885/35615
dc.publisherMassachusetts Medical Society
dc.sourceNew England Journal of Medicine
dc.subjectKeywords: oseltamivir; article; clinical trial; diarrhea; dizziness; drowsiness; drug efficacy; epidemic; epigastric pain; geography; headache; human; infection control; influenza A (H1N1); major clinical study; male; nausea and vomiting; priority journal; question
dc.titleOseltamivir Ring Prophylaxis for Containment of 2009 H1N1 Influenza Outbreaks
dc.typeJournal article
local.bibliographicCitation.issue23
local.bibliographicCitation.lastpage2174
local.bibliographicCitation.startpage2166
local.contributor.affiliationLee, Vernon, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationYap, Jonathan, Singapore Ministry of Defence
local.contributor.affiliationCook, Alex R, National University of Singapore
local.contributor.affiliationChen, Mark, Tan Tock Seng Hospital Singapore
local.contributor.affiliationTay, Joshua K, Ministry of Defence
local.contributor.affiliationTan, Boon Huan, DSO National Laboratories
local.contributor.affiliationLoh, Jin Phang, DSO National Laboratories
local.contributor.affiliationChew, Seok Wei, DSO National Laboratories
local.contributor.affiliationKoh, Wee Hong, DSO National Laboratories
local.contributor.affiliationLin, Raymond T P, Ministry of Health, Singapore
local.contributor.affiliationCui, Lin, Ministry of Health, Singapore
local.contributor.affiliationLee, Charlie W.H, Genome Institute of Singapore
local.contributor.affiliationSung, Wing-Kin, Genome Institute of Singapore
local.contributor.affiliationWong, Christopher W., Genome Institute of Singapore
local.contributor.affiliationHibberd, Martin L., Genome Institute of Singapore
local.contributor.affiliationKang, Wee Lee, Singapore Armed Forces
local.contributor.affiliationSeet, Benjamin, Singapore Armed Forces
local.contributor.affiliationTambyah, Paul A., Ministry of Defence
local.contributor.authoruidLee, Vernon, u4758393
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor111706 - Epidemiology
local.identifier.ariespublicationu4637548xPUB126
local.identifier.citationvolume362
local.identifier.doi10.1056/NEJMoa0908482
local.identifier.scopusID2-s2.0-77953520245
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Lee_Oseltamivir_Ring_Prophylaxis_2010.pdf
Size:
324.27 KB
Format:
Adobe Portable Document Format